BioCentury
ARTICLE | Company News

Theravance, Merck deal

October 22, 2012 7:00 AM UTC

Theravance and Merck partnered to discover, develop and commercialize small molecules directed toward an undisclosed target for hypertension and heart failure. Theravance will be responsible for disco...